te Boekhorst Paul Francis Olivier — SEC Form 4 filings

SEC reporting owner CIK 2095704. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-11-12 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IMMUCELL CORP /DE/ (ICCC)President and CEO, Director66 legs · 23,815 sh · $156,0773

Form 4 filings — te Boekhorst Paul Francis Olivier

FiledFormIssuerReported transactionsSource
2026-06-224IMMUCELL CORP /DE/ (ICCC)Purchase (P): 8,000 @ $9.49EDGAR
2026-03-234/AIMMUCELL CORP /DE/ (ICCC)Grant/award (A): 109,500 (derivative) @ $0EDGAR
2026-01-294IMMUCELL CORP /DE/ (ICCC)Grant/award (A): 110,000 (derivative) @ $0EDGAR
2025-12-044/AIMMUCELL CORP /DE/ (ICCC)Purchase (P): 3,598 @ $5.04 · Purchase (P): 2,432 @ $5.50EDGAR
2025-12-034IMMUCELL CORP /DE/ (ICCC)Purchase (P): 3,708 @ $4.87 · Purchase (P): 2,556 @ $5.00 · Purchase (P): 3,521 @ $5.04EDGAR
2025-11-124IMMUCELL CORP /DE/ (ICCC)Grant/award (A): 74,277 (derivative) @ $6.10EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2095704 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →